Taking too much CBD typically leads to drowsiness, diarrhea, and changes in appetite, though the most concerning documented risk at high doses is liver stress. Unlike THC, CBD does not produce a “high” or life-threatening overdose, but that does not mean unlimited amounts are harmless. Clinical trials using prescription-strength doses have uncovered a pattern of side effects that get worse as the dose climbs, and some of these effects are serious enough to require medical attention.
The Most Common Side Effects
The side effects that show up most frequently in clinical research are tiredness, diarrhea, and changes in appetite or weight.1PubMed Central. An Update on Safety and Side Effects of Cannabidiol: A Review of Clinical Data and Relevant Animal Studies These tend to appear at doses well above what most people take from over-the-counter products. In clinical settings, where patients with epilepsy receive CBD at doses ranging from around 5 to 20 mg per kilogram of body weight daily, the most frequently reported problems are sedation, somnolence, fatigue, and lethargy.2PubMed Central. Cannabidiol Adverse Effects and Toxicity For an average adult, 20 mg/kg works out to roughly 1,500 mg per day, which is far more than the 25 to 50 mg found in a typical consumer product.
A systematic review and meta-analysis of randomized trials found that people taking CBD were significantly more likely than those on placebo to experience decreased appetite, diarrhea, somnolence, and sedation. The odds of sedation were roughly four times higher than with placebo, and the odds of decreased appetite were about three and a half times higher.3Neuropsychopharmacology. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials These are not rare idiosyncratic reactions; they are predictable, dose-related effects that become more common as the amount of CBD goes up.
Liver Stress Is the Biggest Medical Concern
The most serious documented risk of taking too much CBD is liver injury. CBD can cause dose-dependent elevations in liver enzymes, the blood markers doctors use to check whether the liver is under strain. A 2025 randomized trial in otherwise healthy adults found that roughly 6% of participants receiving CBD developed liver enzyme levels more than three times the normal upper limit after four weeks of dosing. Five of those individuals had elevations exceeding five times the normal limit, accompanied by signs of an immune-mediated reaction. Nobody in the placebo group showed these changes.4JAMA Internal Medicine. Cannabidiol and Liver Enzyme Level Elevations in Healthy Adults: A Randomized Clinical Trial
A broader meta-analysis confirmed these findings across both patient and healthy populations, estimating that the risk of liver enzyme elevation was nearly six times higher with CBD than placebo. Drug-induced liver injury meeting formal diagnostic criteria occurred in about 3% of CBD recipients. No cases of severe liver failure were reported, though researchers noted that in most cases, the CBD was either stopped or reduced once the elevations were caught. Whether the damage would have progressed to something worse if the dose had continued is an open question.5PubMed Central. Clinical guidance for cannabidiol‐associated hepatotoxicity: A narrative review The risk climbs with higher doses and is compounded when CBD is taken alongside other drugs that tax the liver, particularly the seizure medication valproate.6ScienceDirect. Advances and Challenges in Modeling Cannabidiol Pharmacokinetics and Hepatotoxicity
This is worth emphasizing because liver injury from CBD is usually silent. You would not feel it happening. It only shows up on a blood test. Prescription CBD (Epidiolex) carries a black-box warning about liver risk, and patients on it get regular blood work. People self-dosing with unregulated products have no such monitoring.
CBD Interferes with Other Medications
One of the less intuitive risks of taking too much CBD is its potential to change how your body handles other drugs. CBD is a potent inhibitor of several liver enzymes responsible for metabolizing a wide range of medications.7PubMed. Cannabinoids and Cytochrome P450 Interactions When CBD ties up these enzymes, other drugs that rely on them can build up to higher-than-intended levels in your blood, essentially making their dose stronger than your doctor prescribed.
Lab studies show that CBD inhibits enzymes across the board, with particularly strong effects on CYP2C9, an enzyme involved in processing many common medications.8PubMed. Cannabinoid Interactions with Cytochrome P450 Drug Metabolism: a Full-Spectrum Characterization In clinical terms, this translates to real interactions. CBD has been shown to interact with anti-epileptic drugs, antidepressants, opioid painkillers, acetaminophen, and alcohol, among others.9PubMed Central. Cannabidiol Interactions with Medications, Illicit Substances, and Alcohol: a Comprehensive Review In one controlled study, taking CBD alongside the seizure medication clobazam caused levels of a clobazam metabolite to roughly triple.10PubMed Central. A Phase 1, Open-Label, Pharmacokinetic Trial to Investigate Possible Drug-Drug Interactions Between Clobazam, Stiripentol, or Valproate and Cannabidiol in Healthy Subjects
The higher the dose of CBD, the more enzyme activity it blocks, and the more significant these interactions become. If you take any prescription medication and are considering CBD, this is the single most important reason to talk to your doctor or pharmacist first. The interaction risk is not hypothetical; it has been measured in human trials.
More Is Not Always Better for Anxiety or Pain
People often assume that if a little CBD helps, more will help more. The evidence actually points in the opposite direction for some effects. In a study of simulated public speaking, 300 mg of CBD significantly reduced anxiety compared to placebo, but both 150 mg and 600 mg did not. The response followed an inverted U-shaped curve, meaning the middle dose worked and both the lower and higher doses failed.11PubMed Central. Cannabidiol presents an inverted U-shaped dose-response curve in a simulated public speaking test
A similar pattern has been observed for pain. A scoping review found that 200 mg of CBD increased pain threshold, while higher doses of 400 and 800 mg actually decreased it relative to placebo.12Pain Medicine. Biphasic effects of cannabis and cannabinoid therapy on pain severity, anxiety, and sleep disturbance: a scoping review Taking too much CBD does not just waste money; for some outcomes, it could actually reverse the benefit you were hoping to get.
What It Does Not Do: Impair Your Thinking Like THC
One reassuring finding is that even at very high doses, CBD does not produce cognitive impairment or feelings of intoxication the way THC does. A dose-ranging trial tested CBD at 15, 300, and 1,500 mg and found no impairment of cognition or driving ability at any dose. Participants did not feel intoxicated.13PubMed Central. Effects of cannabidiol on simulated driving and cognitive performance: A dose-ranging randomised controlled trial Multiple driving studies have reached the same conclusion: CBD alone does not impair driving performance.14PubMed Central. Recent Advances in the Science of Cannabis-Impaired Driving
That said, a meta-analysis pooling results across 16 trials did detect a tiny effect, barely measurable on objective tasks. When researchers looked more closely, they found this signal was driven almost entirely by self-reported sedation rather than actual performance decline. On objective cognitive and motor tasks, the effect was essentially zero.15Neuropsychopharmacology. Does acute cannabidiol (CBD) use impair performance? A meta-analysis and comparison with placebo and delta-9-tetrahydrocannabinol (THC) So while high-dose CBD can make you feel drowsy, it is not going to leave you cognitively impaired in the way alcohol or THC would. That distinction matters if your concern is about accidentally taking too much before driving or working.
Blood Pressure and Heart Rate
CBD has a modest blood-pressure-lowering effect. A crossover study in healthy volunteers found that a single 600 mg dose reduced resting systolic blood pressure by about 6 mmHg and also lowered the blood pressure spike that normally accompanies stress. Heart rate increased slightly to compensate.16PubMed Central. A single dose of cannabidiol reduces blood pressure in healthy volunteers in a randomized crossover study A separate trial confirmed the acute drop in mean arterial pressure after a single dose but found that the effect did not persist after seven days of repeated dosing.17PubMed Central. The effects of acute and sustained cannabidiol dosing for seven days on the haemodynamics in healthy men: A randomised controlled trial
For most healthy people, a few points of blood pressure reduction is not a problem. But if you already take medication for low blood pressure, or if you are on blood-pressure-lowering drugs and add a large dose of CBD on top, the combined effect could potentially cause dizziness or lightheadedness. This is particularly relevant given CBD’s ability to alter the metabolism of other drugs, as noted above.
Poison Control Data Shows Most Cases Are Not Severe
Real-world data from poison control centers offers a useful reality check. Between 2019 and 2020, roughly 1,600 CBD exposure cases were reported to the U.S. National Poison Data System. The most common symptoms were mild: slight drowsiness, elevated heart rate, dizziness, vomiting, and nausea. About 13% of cases were rated as moderate or severe. There were no deaths.18The American Journal of Emergency Medicine. Epidemiology of cannabidiol related cases reported in the National Poison Data System – 2019-2020
A larger analysis covering 2014 to 2021 identified over 6,400 CBD-related cases. The vast majority involved non-FDA-approved products rather than prescription CBD. Children aged 2 to 12 accounted for more than a third of all cases, usually through unintentional exposure, which makes sense given that many CBD products come as gummies, chocolates, and flavored liquids that look like candy. Among single-product exposures, 44 cases were classified as major medical outcomes, and all of those involved unregulated products.19PubMed Central. Cannabidiol exposures in the United States, National Poison Data System, July 2014–June 2021
The pediatric angle deserves attention. When a child gets into a bottle of CBD gummies, the dose relative to their body weight can be enormous. Clinical data from pediatric epilepsy trials shows that children on CBD are more likely to experience diarrhea, somnolence, sedation, and serious adverse events compared to placebo, with the odds of serious events nearly three times higher. Clobazam co-therapy and higher dosages increase the risk further.20PubMed Central. Clinical efficacy and safety of cannabidiol for pediatric refractory epilepsy indications: A systematic review and meta-analysis Keep CBD products stored where children cannot reach them, the same way you would with any medication.
You Might Not Know How Much You Are Actually Taking
A complicating factor in all of this is that the label on a CBD product may not reflect what is actually inside. A study testing 84 CBD products sold online found that only about 31% were accurately labeled. Roughly 43% contained more CBD than stated, and about 26% contained less.21JAMA. Labeling Accuracy of Cannabidiol Extracts Sold Online A more recent evaluation of 80 products found similar problems: 46% had CBD concentrations at least 10% different from the label claim, with some products off by as much as 30 mg/mL.22PubMed Central. Label accuracy of unregulated cannabidiol (CBD) products: measured concentration vs. label claim
Beyond inaccurate CBD content, products may also contain undisclosed THC or contaminants like pesticides, heavy metals, and mold.23PubMed Central. Labeling of Cannabidiol Products: A Public Health Perspective This means that some “CBD overdose” experiences people report, particularly ones involving unexpected intoxication, anxiety, or cognitive impairment, may not actually be caused by CBD at all but by unlisted THC or other adulterants. It also means that someone trying to stay at a moderate dose might be inadvertently taking much more than intended. If you are going to use CBD, choosing products that provide independent third-party lab testing is one of the few ways to get some assurance about what you are actually consuming.
Immune Suppression at High Doses
CBD has broad immunosuppressive properties. Research shows that it suppresses the activation of various immune cell types, promotes the death of certain immune cells, and shifts the balance toward regulatory cells that dial down immune responses.24PubMed Central. Immune Responses Regulated by Cannabidiol This includes effects on T cell activity, inflammatory signaling molecules, and macrophage function.25PubMed Central. Cannabidiol as an immune modulator: A comprehensive review
For someone with an overactive immune system, such as in autoimmune conditions, this could theoretically be helpful. But for a healthy person taking large amounts of CBD daily, chronic immune suppression is not something to dismiss. Interestingly, the meta-analysis of randomized trials found that CBD was associated with a significantly higher risk of pneumonia compared to placebo.3Neuropsychopharmacology. Adverse effects of cannabidiol: a systematic review and meta-analysis of randomized clinical trials Whether that finding holds up as a real-world concern for typical consumer doses is not yet clear, but it is a signal that the immune effects are not purely theoretical.
Pregnancy and CBD
Animal studies have raised red flags about CBD use during pregnancy. In rats, CBD exposure during pregnancy resulted in pups that were about 10% smaller, with placentas showing defective blood vessel formation and altered nutrient transport.26PubMed Central. Cannabidiol Exposure During Rat Pregnancy Leads to Labyrinth-Specific Vascular Defects in the Placenta and Reduced Fetal Growth A mouse study found that oral CBD during pregnancy impaired the remodeling of arteries that supply the placenta, restricted fetal growth, and caused lasting behavioral changes in offspring: male pups showed altered aggression and metabolism, while females had impaired spatial learning.27PubMed Central. The impact of oral cannabis consumption during pregnancy on maternal spiral artery remodelling, fetal growth and offspring behaviour in mice
These are animal studies, and doses used in rodent research are not directly translatable to humans. But both studies independently point toward the same problem: disrupted placental blood supply leading to smaller offspring and developmental consequences. No controlled human trials on CBD in pregnancy exist for obvious ethical reasons, and given the current evidence, the prudent approach is to avoid CBD during pregnancy entirely.
The FDA’s Enforcement Problem
The FDA has approved exactly one CBD medication, Epidiolex, for certain seizure disorders. Everything else sold as CBD, the oils, gummies, capsules, and topicals filling store shelves, exists in a regulatory gray zone. The FDA has repeatedly issued warning letters to companies making prohibited health claims about their CBD products, including claims that CBD treats cancer, Alzheimer’s disease, and other serious conditions.28PubMed Central. Health Claims About Cannabidiol Products: A Retrospective Analysis of U.S. Food and Drug Administration Warning Letters from 2015 to 2019 But these warning letters are requests for voluntary compliance, not enforcement actions with teeth.
This matters for the “too much CBD” question because it means there is no standardized dosing guidance, no required safety monitoring, and no guarantee that the product on the shelf has been tested for purity, potency, or contaminants. Prescription CBD comes with clear dosing, liver-function monitoring, and drug-interaction warnings. The supplement-style product you buy online comes with none of those guardrails. The risk of accidentally taking too much is not just about someone deliberately exceeding a recommended dose; it is baked into a market where accurate labeling is the exception rather than the rule.
How CBD Accumulates in the Body
CBD is fat-soluble, which means it does not just pass through your system cleanly. Over time, it builds up in fatty tissue. An animal study tracking CBD accumulation over 28 days found that fat tissue levels were roughly 10 to 100 times higher than levels in the liver or muscle.29PubMed Central. Cannabidiol (CBD) Dosing: Plasma Pharmacokinetics and Effects on Accumulation in Skeletal Muscle, Liver and Adipose Tissue Human pharmacokinetic data also shows substantial variability between individuals in how much CBD reaches the bloodstream after an oral dose, meaning two people taking the same amount can end up with very different levels in their body.30Medical Cannabis and Cannabinoids. Pharmacokinetic Variability of Oral Cannabidiol and Its Major Metabolites after Short-Term High-Dose Exposure in Healthy Subjects
This has a practical implication: the effects of chronic high-dose use may not mirror what you experience on day one. If you keep taking large amounts daily, tissue levels creep upward even if your daily dose stays the same. A dose that felt fine during the first week might produce more side effects by week four as tissue stores accumulate. The liver enzyme elevations seen in clinical trials typically emerge after several weeks of dosing, not immediately, which is consistent with this accumulation pattern.